Modulation of stroke risk in chronic kidney disease

Por Arnold, Julia, Sims, Don, Ferro, Charles J.
Publicado no Clin Kidney J (2016)

Evaluating the effects of sevelamer carbonate on cardiovascular structure and function in chronic renal impairment in Birmingham: the CRIB-PHOS randomised controlled trial

Por Chue, Colin D, Townend, Jonathan N, Steeds, Richard P, Ferro, Charles J
Publicado em 2011

Impaired cholinergic dilator response of resistance arteries isolated from patients with Raynaud’s disease

Por Smith, Paula J W, Ferro, Charles J, McQueen, Daniel S, Webb, David J
Publicado em 1999

Association between periodontitis and mortality in stages 3–5 chronic kidney disease: NHANES III and linked mortality study

Por Sharma, Praveen, Dietrich, Thomas, Ferro, Charles J., Cockwell, Paul, Chapple, Iain L.C.
Publicado no J Clin Periodontol (2016)

Serum endotrophin, a type VI collagen cleavage product, is associated with increased mortality in chronic kidney disease

Por Fenton, Anthony, Jesky, Mark D., Ferro, Charles J., Sørensen, Jacob, Karsdal, Morten A., Cockwell, Paul, Genovese, Federica
Publicado no PLoS One (2017)

The safety and tolerability of spironolactone in patients with mild to moderate chronic kidney disease

Por Edwards, Nicola C, Steeds, Richard P, Chue, Colin D, Stewart, Paul M, Ferro, Charles J, Townend, Jonathan N
Publicado em 2012

Impaired circumferential and longitudinal myocardial deformation in early stage chronic kidney disease: the earliest features of uremic cardiomyopathy

Por Edwards, Nicola C, Noori, Abdullah, Chue, Colin D, Moody, William E, Ferro, Charles J, Townend, Jonathan N, Steeds, Richard
Publicado em 2013

Early stage chronic kidney disease: a paradigm for diffuse fibrosis and clinical progression

Por Edwards, Nicola C, Moody, William E, Yuan, Mengshi, Flanagan, Shonagh, Ferro, Charles J, Townend, John N, Steeds, Richard P
Publicado em 2014

Allopurinol Is an Independent Determinant of Improved Arterial Stiffness in Chronic Kidney Disease: A Cross-Sectional Study

Por Ng, Khai P., Stringer, Stephanie J., Jesky, Mark D., Yadav, Punit, Athwal, Rajbir, Dutton, Mary, Ferro, Charles J., Cockwell, Paul
Publicado em 2014

Substance P-induced vasodilatation is mediated by the neurokinin type 1 receptor but does not contribute to basal vascular tone in man

Por Newby, David E, Sciberras, David G, Ferro, Charles J, Gertz, Barry J, Sommerville, David, Majumdar, Anup, Lowry, Richard C, Webb, David J
Publicado em 1999

Results and lessons from the Spironolactone To Prevent Cardiovascular Events in Early Stage Chronic Kidney Disease (STOP-CKD) randomised controlled trial

Por Ng, Khai P, Jain, Poorva, Gill, Paramjit S, Heer, Gurdip, Townend, Jonathan N, Freemantle, Nick, Greenfield, Sheila, McManus, Richard J, Ferro, Charles J
Publicado no BMJ Open (2016)

Cardiovascular Effects of Sevelamer in Stage 3 CKD

Por Chue, Colin D., Townend, Jonathan N., Moody, William E., Zehnder, Daniel, Wall, Nadezhda A., Harper, Lorraine, Edwards, Nicola C., Steeds, Richard P., Ferro, Charles J.
Publicado em 2013

Normative annual changes in left ventricular volumes, mass and function among healthy adults: a prospective cardiac magnetic resonance imaging study

Por Moody, William E, Edwards, Nicola C, Chue, Colin D, Taylor, Robin J, Kuan Li, Andrew You, Ferro, Charles J, Townend, John N, Steeds, Richard P
Publicado em 2014

Aortic Calcification and Femoral Bone Density Are Independently Associated with Left Ventricular Mass in Patients with Chronic Kidney Disease

Por Chue, Colin D., Wall, Nadezhda A., Crabtree, Nicola J., Zehnder, Daniel, Moody, William E., Edwards, Nicola C., Steeds, Richard P., Townend, Jonathan N., Ferro, Charles J.
Publicado em 2012

Cytomegalovirus Seropositivity Is Associated with Increased Arterial Stiffness in Patients with Chronic Kidney Disease

Por Wall, Nadezhda A., Chue, Colin D., Edwards, Nicola C., Pankhurst, Tanya, Harper, Lorraine, Steeds, Richard P., Lauder, Sarah, Townend, Jonathan N., Moss, Paul, Ferro, Charles J.
Publicado em 2013

Health-Related Quality of Life Impacts Mortality but Not Progression to End-Stage Renal Disease in Pre-Dialysis Chronic Kidney Disease: A Prospective Observational Study

Por Jesky, Mark D., Dutton, Mary, Dasgupta, Indranil, Yadav, Punit, Ng, Khai Ping, Fenton, Anthony, Kyte, Derek, Ferro, Charles J., Calvert, Melanie, Cockwell, Paul, Stringer, Stephanie J.
Publicado no PLoS One (2016)

Comparison of magnetic resonance feature tracking for longitudinal strain calculation with spatial modulation of magnetization imaging analysis

Por Moody, William E, Taylor, Robin J, Edwards, Nicola C, Umar, Fraz, Chue, Colin D, Taylor, Tiffany J, Ferro, Charles J, Townend, Jonathan N, Leyva, Francisco, Steeds, Richard
Publicado em 2013

Cardiovascular Effects of Unilateral Nephrectomy in Living Kidney Donors

Por Moody, William E., Ferro, Charles J., Edwards, Nicola C., Chue, Colin D., Lin, Erica Lai Sze, Taylor, Robin J., Cockwell, Paul, Steeds, Richard P., Townend, Jonathan N.
Publicado no Hypertension (2016)

Effect of A Reduction in glomerular filtration rate after NEphrectomy on arterial STiffness and central hemodynamics: Rationale and design of the EARNEST study()

Por Moody, William E., Tomlinson, Laurie A., Ferro, Charles J., Steeds, Richard P., Mark, Patrick B., Zehnder, Daniel, Tomson, Charles R., Cockcroft, John R., Wilkinson, Ian B., Townend, Jonathan N.
Publicado em 2014

Spironolactone to prevent cardiovascular events in early-stage chronic kidney disease (STOP-CKD): study protocol for a randomized controlled pilot trial

Por Ng, Khai P, Jain, Poorva, Heer, Gurdip, Redman, Val, Chagoury, Odette L, Dowswell, George, Greenfield, Sheila, Freemantle, Nick, Townend, Jonathan N, Gill, Paramjit S, McManus, Richard J, Ferro, Charles J
Publicado em 2014